Back to trials
completed
Phase 4

NCT02984176

Simethicone: Does it Improve Operative Field and Postoperative Pain?

Sponsored by Woman's Health University Hospital, Egypt

Summary

Simethicone is an oral anti-foaming agent that reduces bloating, abdominal discomfort, and abdominal pain by promoting the clearance of excessive gas along the gastrointestinal tract. The investigators objective is to evaluate the efficacy and safety of preoperative oral simethicone for bowel preparation in gynecological laparoscopies.

Eligibility Criteria

Inclusion Criteria: * Infertile patients * aged 20 - 40 years old * scheduled for laparoscopy Exclusion Criteria: * Women were excluded from the study if patients had one or more of the following: * scar of previous operation, uterine mass, severe endometriosis, suspicion of malignancy, history of allergic reaction to study drugs, psychiatric disorders and patient refusal

Why you can trust this information
Registry sourcesclinicaltrials_gov
Source last updated12/7/2016
Clintriva indexed9/27/2026, 9:23:16 PM
Registry records1
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateAug 1, 2014
CompletionJul 1, 2015
Enrollment0/100
Country—

Conditions

Simethicone
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.